These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2054507)

  • 1. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
    Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN
    Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
    Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
    Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ; Bennett AM; Phillpotts RJ
    J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
    Arya SC; Agarwal N
    Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
    [No Abstract]   [Full Text] [Related]  

  • 14. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus].
    Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa
    Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
    Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
    Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.
    Kowalski J; Adkins K; Gangolli S; Ren J; Arendt H; DeStefano J; Obregon J; Tummolo D; Natuk RJ; Brown TP; Parks CL; Udem SA; Long D
    Vaccine; 2007 Mar; 25(12):2296-305. PubMed ID: 17239997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental evaluation of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Selivanenko GM; Chernikova NK; Pshenichnov VA
    Vopr Virusol; 1991; 36(3):243-5. PubMed ID: 1891883
    [No Abstract]   [Full Text] [Related]  

  • 19. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
    Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
    PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
    Jahrling PB; Stephenson EH
    J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.